StatPearls [Internet], 2024 Jan Avinoam Shiran, Eric Remer, Ihab Asmer, Basheer Karkabi, Eran Zittan, Aliza Cassel, Mira Barak, Orit Rozenberg, Khaled Karkabi, Moshe Y Flugelman
Dissatisfaction with treatment frequency may be a reason for patients not to adhere fully to their prescribed regimen and may be ameliorated by a switch from a once- or twice-daily to a once-weekly GLP-1 receptor agonist
There's more to Lilly's momentum than just its past results and its newest GLP-1, though: the company anticipates continued rapid growth, as reflected by significant increases in guidance
Better absorption: B12 shots are much better at getting the vitamin into your body than pills
Efficacy of GLP-1 RA approved for weight management in patients with and without diabetes: A narrative review
Handling and use of these products should be restricted to suitably qualified professionals.